FOI release

MHRA Yellow Card Contact Us Form Submission

Case reference FOI2026/00068

Received 22 January 2026

Published 24 March 2026

Request

I would like to submit a freedom of information request regarding the drug analysis print for immunoglobulin normal. There is aggregated data on drug analysis prints, however I am looking for more granular data. Specifically, I please request a breakdown of the type and frequency of all different adverse events reported within skin and subcutaneous tissue for all subcutaneous immunoglobulin brands, broken down by brand, in the UK since 1st January 2015 to the most current date available reported via the yellow card system and pharmaceutical industry. Route of administration to include: - 'intravenous bolus; subcutaneous' - 'other; subcutaneous' - 'subcutaneous'. The output should include - all sexes - age groups - reporter types - severity.

Response

See attached

Documents

• FOI2026_00068 (redacted).pdf (956.5 KB)
• FOI2026_00068 Immunoglobulin Normal(1).csv (524 B)
• FOI2026_00068 Immunoglobulin Normal(2).csv (652 B)
• FOI2026_00068 Immunoglobulin Normal(3).csv (1.7 KB)
• FOI2026_00068 Immunoglobulin Normal(4).csv (640 B)
• FOI2026_00068 Immunoglobulin Normal(5).csv (669 B)
• FOI2026_00068 Immunoglobulin Normal.csv (524 B)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.